Differences of longitudinal plasma biomarkers between single memory domain and multidomain subject cognitive decline: Evidence from SILCODE
M Wei, X Yu, S Hu, W Hu, R Shi… - Journal of …, 2025 - journals.sagepub.com
Background Plasma biomarkers demonstrated potential in identifying amyloid pathology in
early Alzheimer's disease. Different subtypes of subjective cognitive decline (SCD) may lead …
early Alzheimer's disease. Different subtypes of subjective cognitive decline (SCD) may lead …
Tau Pathology Drives Disease‐Associated Astrocyte Reactivity in Salt‐Induced Neurodegeneration
TY Rui, HZ Huang, K Zheng, HW Fan… - Advanced …, 2025 - Wiley Online Library
Dietary high salt intake is increasingly recognized as a risk factor for cognitive decline and
dementia, including Alzheimer's disease (AD). Recent studies have identified a population …
dementia, including Alzheimer's disease (AD). Recent studies have identified a population …
Plasma N‐terminal tau fragment is an amyloid‐dependent biomarker in Alzheimer's disease
INTRODUCTION Novel fluid biomarkers for tracking neurodegeneration specific to
Alzheimer's disease (AD) are greatly needed. METHODS Using two independent well …
Alzheimer's disease (AD) are greatly needed. METHODS Using two independent well …